India’s JB Chem and Pharma meets Q3 profit view on steady domestic demand
(Reuters) – India’s J B Chemicals & Pharmaceuticals reported a bigger third-quarter profit on Tuesday, helped by sustained domestic demand for its drugs for chronic and acute conditions. The drugmaker’s consolidated net profit rose 22% from a year ago to 1.62 billion rupees ($18.6 million) in the quarter, in line with analysts’ average estimate, as …
India’s JB Chem and Pharma meets Q3 profit view on steady domestic demand Read More »





